These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37230521)

  • 21. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.
    Kosiborod M; Rasmussen HS; Lavin P; Qunibi WY; Spinowitz B; Packham D; Roger SD; Yang A; Lerma E; Singh B
    JAMA; 2014 Dec; 312(21):2223-33. PubMed ID: 25402495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia.
    Yoo N; Song YB; Dubinsky I; Altshuler J
    Ann Pharmacother; 2023 Sep; 57(9):1044-1052. PubMed ID: 36637028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial.
    Anker SD; Kosiborod M; Zannad F; Piña IL; McCullough PA; Filippatos G; van der Meer P; Ponikowski P; Rasmussen HS; Lavin PT; Singh B; Yang A; Deedwania P
    Eur J Heart Fail; 2015 Oct; 17(10):1050-6. PubMed ID: 26011677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure.
    Tardif JC; Rouleau J; Chertow GM; Al-Shurbaji A; Lisovskaja V; Gustavson S; Zhao Y; Bouabdallaoui N; Desai AS; Chernyavskiy A; Evsina M; Merkely B; McMurray JJV; Pfeffer MA
    ESC Heart Fail; 2023 Apr; 10(2):1066-1076. PubMed ID: 36564955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperkalaemia and potassium binders: Retrospective observational analysis looking at the efficacy and cost effectiveness of calcium polystyrene sulfonate and sodium zirconium cyclosilicate.
    Huda AB; Langford C; Lake J; Langford N
    J Clin Pharm Ther; 2022 Dec; 47(12):2170-2175. PubMed ID: 36114759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evaluation of sodium zirconium cyclosilicate: a new treatment option for hyperkalaemia in China.
    Lu Y; Liu BC; Liu H
    Expert Opin Pharmacother; 2023 Feb; 24(3):301-308. PubMed ID: 36617700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multicentre, observational, retrospective cohort of hyperkalaemia burden at haemodialysis facility-level in China: the Visualize-HD study protocol.
    Zhao X; Zuo L
    BMJ Open; 2023 Sep; 13(9):e066394. PubMed ID: 37734899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Course of Hyperkalemia in Patients on Hemodialysis.
    Spinowitz B; Fishbane S; Fukagawa M; Ford M; Guzman N; Rastogi A
    Int J Nephrol; 2022; 2022():6304571. PubMed ID: 35531468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum potassium response to single-dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients.
    Lewis H; Stamper B; Yungkurth AC
    Pharmacotherapy; 2024 Jan; 44(1):13-21. PubMed ID: 37475499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Sodium Zirconium Cyclosilicate for Treatment of Hyperkalemia: An 11-Month Open-Label Extension of HARMONIZE.
    Roger SD; Spinowitz BS; Lerma EV; Singh B; Packham DK; Al-Shurbaji A; Kosiborod M
    Am J Nephrol; 2019; 50(6):473-480. PubMed ID: 31658466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost effectiveness of sodium zirconium cyclosilicate for the treatment of hyperkalaemia in patients with CKD in Norway and Sweden.
    Kim K; Fagerström J; Chen G; Lagunova Z; Furuland H; McEwan P
    BMC Nephrol; 2022 Aug; 23(1):281. PubMed ID: 35953778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of different potassium-lowering regimens on acute hyperkalemia in hemodialysis patients: a real-world, retrospective study.
    Yao L; Xing X; Li Y; Zhang F; Li P; Liang X; Wang P
    J Transl Med; 2022 Jul; 20(1):333. PubMed ID: 35879718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin glucose infusion versus nebulised salbutamol versus combination of salbutamol and insulin glucose in acute hyperkalaemia in the emergency room: protocol for a randomised, multicentre, controlled study (INSAKA).
    Montassier E; Lemoine L; Hardouin JB; Rossignol P; Legrand M
    BMJ Open; 2020 Aug; 10(8):e039277. PubMed ID: 32847923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials.
    Amin AN; Menoyo J; Singh B; Kim CS
    BMC Nephrol; 2019 Dec; 20(1):440. PubMed ID: 31791288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients.
    Sullivan E; Ruegger M; Dunne I; Sutaria N; Towers WF
    Am J Health Syst Pharm; 2023 Sep; 80(18):1238-1246. PubMed ID: 37335862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An evaluation of sodium zirconium cyclosilicate as a treatment option for hyperkalemia.
    Takkar C; Nassar T; Qunibi W
    Expert Opin Pharmacother; 2021 Jan; 22(1):19-28. PubMed ID: 32892634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Replacing salt with low-sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women.
    Brand A; Visser ME; Schoonees A; Naude CE
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD015207. PubMed ID: 35944931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department.
    Hasara S; Dubey J; Amatea J; Finnigan N
    Am J Emerg Med; 2023 Mar; 65():59-64. PubMed ID: 36586223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.